Other languages Alembic Limited NSE India S.E.

Equities

ALEMBICLTD

INE426A01027

Market Closed - NSE India S.E. Other stock markets 07:40:29 2024-05-08 EDT			5-day change	1st Jan Change
89.2 ^INR	+1.08%		-3.78%	-1.44%

04-02	Alembic Pharmaceuticals Gets US FDA Tentative Nod for Generic Breast Cancer Treatment	MT
04-01	Alembic Limited Announces Cessation of C. P. Buch as an Independent Director	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alembic Pharmaceuticals Gets US FDA Tentative Nod for Generic Breast Cancer Treatment	04-02
Alembic Limited Announces Cessation of C. P. Buch as an Independent Director	04-01
Crisil Keeps AA+ Rating on Alembic Pharmaceuticals' Bank Loans with Stable Outlook	03-08
ICRA Affirms AA- Rating on Alembic's Bank Financing; Outlook Stable	02-29
Indian shares seen muted tracking broader Asian equities	02-25
Alembic Pharmaceuticals Fully Resumes Operations at Manufacturing Unit in South Sikkim, India	02-23
Alembic Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-14
Alembic Pharmaceuticals' Consolidated Net Profit Jumps in Fiscal Q3; EPS Tops Estimates	02-06
Alembic Pharmaceuticals' Consolidated Profit Climbs in Fiscal Q3, EPS Beats Estimates	02-06
India's Alembic Pharma beats Q3 profit view on strong domestic, US sales	02-05
Alembic Pharmaceuticals Expects Operations at Sikkim, India Units to Be Restores in Two Months	01-05
Alembic Pharmaceuticals Extends Corporate Guarantee to US-Based Arm to Secure Credit	01-02
Alembic Pharmaceuticals Logs Slightly Higher Consolidated Profit in Fiscal Q2; EPS Misses Estimates	11-08
India's Alembic Pharma Q2 profit roughly in-line with estimates	11-07
Alembic Limited Appoints Dr. Girish Hirode as an Independent Director of the Company	23-08-10
Alembic Limited Announces Company Secretary & Compliance Officer Changes	23-08-10
Alembic Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-10
Alembic Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-10
Alembic Pharmaceuticals Turns to Profit in Fiscal Q1	23-08-08
India's Alembic Pharma posts Q1 profit on strong sales	23-08-04

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Alembic Limited NSE India S.E.

Equities

ALEMBICLTD

INE426A01027

Other languages

Filters